* While partnerships initially may be more expensive than the traditional approach to outsourcing, they are expected to help drug sponsors better manage costs and reduce redundancy between sponsors and service providers. * Flexibility and adaptability, supported by open and frequent communication, are key to developing the high level of collaboration that makes partnership-based networks work. SCHEDULED TUFTS CSDD EXECUTIVE FORUM ROUNDTABLES Upcoming Tufts CSDD Executive Forum Roundtable meetings will focus on the following: Sept. 10, 2009 -- Best R&D Practices of Top Pharma/Biotech Performers Nov. 12, 2009 -- Comparative Approaches to Capacity Forecasting Feb. 25, 2010 -- Improving ROI and Late Stage Clinical Success Rates May 13, 2010 -- Strategies for Managing Drug Development Risk: Maintaining Portfolio DiversityTo learn more, call 617-636-2170. About the Tufts Center for the Study of Drug Development The Tufts Center for the Study of Drug Development (http://csdd.tufts.edu) at Tufts University provides strategic information to help drug developers, regulators, and policy makers improve the quality and efficiency of pharmaceutical development, review, and utilization. Tufts CSDD, based in Boston, conducts a wide range of in-depth analyses on pharmaceutical issues and hosts symposia, workshops, and public forums, and publishes the Tufts CSDD Impact Report, a bi-monthly newsletter providing analysis and insight into critical drug development issues.
Contact Information: Contact: Tufts Center for the Study of Drug Development Charlene Neu 617-636-2187 Business Communication Strategies Peter Lowy 617-734-9980